Notice Type: Sources Sought Notice
Posted Date: 25-JUL-13
Office Address: Department of Health and Human Services; Food and Drug Administration; Office of Acquisitions and Grants Services; 5630 Fishers Lane, Room 2129 Rockville MD 20857-0001
Subject: Genomic Information Management System
Classification Code: 70 - General purpose information technology equipment
Solicitation Number: FDA-RFI-13-1119904
Contact: Jacob A. O'Hatnick, Contract Specialist, Phone 3018276758, Email email@example.com
Place of Performance (address): FDACollege Park, MD
Place of Performance (zipcode): 20740
Place of Performance Country: US
Description: Department of Health and Human Services
Food and Drug Administration
Office of Acquisitions and Grants Services
Notice to Small Businesses The purpose of this Sources Sought Notice/RFI is to seek declarations of technical capabilities and various information, data, and materials from qualified small business concerns [Woman-owned Small Businesses (WOSB), Historically Underutilized Business Zone (HUBZone), Small Businesses, and Service-Disabled Veteran-owned Small Businesses (SDVOSB)]. Food and Drug Administration intends to provide maximum practicable opportunities in its acquisitions to small business, service-disabled veteran-owned small business, and HUBZone small business. Background This Sources Sought Request for Information (RFI) is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration or its Centers. The purpose of this RFI is to help the FDA understand the industry best practices and technical solutions capable of providing the full range of services described in this RFI and the draft SOW. FDA will use this market research information to assess the market's capability to successfully meet FDA's Genomic Information Management System requirements. FDA welcomes responses from all interested parties. FDA does not intend to make a selection decision or award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted or FDA's use of such information. Acknowledgment of receipt of responses will not be made, nor will respondents be notified of the outcome of the FDA's review of the information received. Additionally, the FDA does not intend to hold discussions concerning this RFI with any interested parties. However, FDA reserves the right to contact vendors if additional information is required.
General Instructions Responses to the RFI should not exceed 10 pages in length. The 10 page limit excludes attachments. They should be submitted via email to Jacob O'Hatnick at by 5:00PM on Monday, July 29th.
A complete response to the RFI should include answers to all of the questions below. Please note that a respondent's failure to provide a complete response to a question will be interpreted to mean that it does not understand the question and does not demonstrate the capability to provide services required. Responses should demonstrate capability, not merely affirm the respondent's capability (e.g.: The response must go beyond the statement that, "XYZ company can deploy a GIMS.").
Questions: 1. Please demonstrate your capability to meet the requirements listed in section 4 of the attached statement of work. 2. Please describe your past performance demonstrating that you have deployed a comparable GIMS that interfaced with at least two or more NGS sequencing platforms, each from different manufacturers 3. Please provide documentation of the size of your business. If you are classified as a small business, Historically Underutilized Business Zone small business, Service Disabled Veteran Owned Small Business, Woman-Owned Small Business and/or SBA 8(a) certified small business. Please provide a capability statement in addition to the other information for acquisition strategy determination. 4. Please provide suggested appropriate North American Industry Classification System (NAICS) code and rationale. 5. Please provide the following: a. Organization name b. DUNS number c. Organization's website d. contact Name e. contact Telephone f. contact E-mail address g. Size designation h. Number of employees in your organization i. Your organization's current and gross revenue 6. Provide information concerning contract vehicles available to be used by the FDA in acquiring the services outlined in the draft SOW (GSA Federal Schedules, Government wide Acquisition Contract, etc.).